Matthew A. Windsor, Ph.D. - Publications
Affiliations: | 2011 | University of Wisconsin, Madison, Madison, WI |
Area:
biologically active polymersYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Windsor MA, Valk PL, Xu S, Banerjee S, Marnett LJ. Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib. Bioorganic & Medicinal Chemistry Letters. 23: 5860-4. PMID 24060487 DOI: 10.1016/J.Bmcl.2013.08.097 | 0.334 | |||
2012 | Windsor MA, Hermanson DJ, Kingsley PJ, Xu S, Crews BC, Ho W, Keenan CM, Banerjee S, Sharkey KA, Marnett LJ. Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes. Acs Medicinal Chemistry Letters. 3: 759-763. PMID 22984634 DOI: 10.1021/Ml3001616 | 0.325 | |||
2009 | Lu D, Windsor MA, Gellman SH, Keck JL. Peptide inhibitors identify roles for SSB C-terminal residues in SSB/exonuclease I complex formation. Biochemistry. 48: 6764-71. PMID 19527069 DOI: 10.1021/Bi900361R | 0.503 | |||
2009 | Müller MM, Windsor MA, Pomerantz WC, Gellman SH, Hilvert D. A rationally designed aldolase foldamer. Angewandte Chemie (International Ed. in English). 48: 922-5. PMID 19090515 DOI: 10.1002/Anie.200804996 | 0.534 | |||
2008 | Horne WS, Boersma MD, Windsor MA, Gellman SH. Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains. Angewandte Chemie (International Ed. in English). 47: 2853-6. PMID 18330876 DOI: 10.1002/Anie.200705315 | 0.435 | |||
Show low-probability matches. |